Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AdVnt Biotechnologies is a leading manufacturer of rapid diagnostic and field screening products specializing in the detection of environmental threats, biowarfare agents, and drugs of abuse. The company's core technology utilizes proprietary antibodies and lateral flow assay platforms to provide results in minutes for first responders, military personnel, and facility managers. Their flagship product lines include BADD™ (Biowarfare Agent Detection Devices) and Pro Strips™, which can detect multiple high-priority pathogens and toxins such as Anthrax, Ricin, and Botulinum toxin. Additionally, AdVnt offers solutions for indoor air quality through its Informant™ mold detection systems and forensic drug screening for substances like Fentanyl and Cocaine. The company maintains high quality standards, including ISO 13485 and cGMP certifications, to ensure the reliability of its field-deployable assays.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ADVNT Biotechnologies.